AbbVie 2013 Annual Report Download - page 159

Download and view the complete annual report

Please find page 159 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

2013 Option Exercises and Stock Vested
The following table summarizes for each named executive officer the number of shares acquired
on the exercise of AbbVie stock options and the number of shares acquired on the vesting of AbbVie
stock awards in 2013:
Option Awards Stock Awards
Number of Number of
Shares Value Shares Value
Acquired On Realized On Acquired On Realized On
Name Exercise (#) Exercise ($) Vesting (#) Vesting ($)
R. Gonzalez ............................. 0 $0 46,199 $1,708,222
L. Schumacher ........................... 20,659 226,374 73,567 2,729,316
W. Chase ............................... 12,179 172,475 20,201 749,633
C. Alban ............................... 145,382 2,552,665 48,600 1,802,928
T. Richmond ............................. 0 0 4,616 173,469
Pension Benefits
During 2013, the named executive officers participated in two AbbVie-sponsored defined benefit
pension plans: the AbbVie Pension Plan, a tax-qualified pension plan; and the AbbVie Supplemental
Pension Plan, a non-qualified supplemental pension plan. The Supplemental Pension Plan also includes
a benefit feature AbbVie uses to attract senior executives who are mid-career hires, which provides an
additional benefit to such participants that is less valuable to participants who have spent most of their
career at the company. Except as provided in AbbVie’s change in control agreements, AbbVie does not
have a policy granting extra years of credited service under the plans. The change in control
agreements are described in the section of this proxy statement captioned ‘‘Potential Payments upon
Termination or Change in Control.’’
The compensation considered in determining the pensions payable to the named executive officers
is the compensation shown in the ‘‘Salary’’ and ‘‘Non-Equity Incentive Plan Compensation’’ columns of
the Summary Compensation Table.
36